Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-01-05

Clinical Trial Update: Telephone Interview of Patients That Participated in the the Pivotal Betaferon MS Trial.

View source ↗

Summary

The document reports that the telephone interview study of patients who participated in Bayer's pivotal Betaseron trial for multiple sclerosis has been complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED